title: Arginase as a new concern in blood transfusion.
authors.affiliation: Institute of Molecular and Cellular Cancer Biology, Cancer Research Centre, CSIC-University of Salamanca, Campus Miguel de Unamuno, Salamanca, Spain.
authors.forename: Faustino
authors.initials: F
authors.lastname: Mollinedo
authors.affiliation: Anaesthesiology and Resuscitation Service, University Hospital of Salamanca, IBSAL, Salamanca, Spain.
authors.forename: Miguel Angel
authors.initials: MA
authors.lastname: Palomero-Rodríguez
authors.affiliation: Anaesthesiology and Resuscitation Service, University Hospital of Salamanca, IBSAL, Salamanca, Spain.
authors.forename: Pilar
authors.initials: P
authors.lastname: Sánchez-Conde
authors.affiliation: Institute of Molecular and Cellular Cancer Biology, Cancer Research Centre, CSIC-University of Salamanca, Campus Miguel de Unamuno, Salamanca, Spain.
authors.forename: Rósula
authors.initials: R
authors.lastname: García-Navas
authors.affiliation: Paediatric Anaesthesiology Service, La Paz University Hospital, Madrid, Spain.
authors.forename: Yolanda
authors.initials: Y
authors.lastname: Laporta-Báez
authors.affiliation: Paediatric Anaesthesiology Service, La Paz University Hospital, Madrid, Spain.
authors.forename: Jesús
authors.initials: J
authors.lastname: de Vicente-Sánchez
authors.affiliation: Paediatric Anaesthesiology Service, La Paz University Hospital, Madrid, Spain.
authors.forename: Luis
authors.initials: L
authors.lastname: Suarez-Gonzalo
mesh_terms: D001119:Arginase / Q000097:blood*; D001120:Arginine / Q000097:blood*; D001793:Blood Preservation / Q000009:adverse effects*; D017707:Erythrocyte Transfusion / Q000009:adverse effects; D006461:Hemolysis; D006801:Humans; D007165:Immunosuppression Therapy; D009504:Neutrophils / Q000201:enzymology; D013997:Time Factors; D065227:Transfusion Reaction
chemical_list: D001120:Arginine; D001119:Arginase